Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-16 Sale | 2026-09-18 4:10 pm | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 12,394 | $16.33 | $202,437 | 123,748 (Direct) | View |
| 2026-09-10 Sale | 2026-09-11 4:10 pm | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 10,185 | $17.62 | $179,457 | 145,715 (Direct) | View |
| 2026-08-28 Sale | 2026-09-01 4:38 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $20 | $13,580 | 165,510 (Direct) | View |
| 2026-08-17 Sale | 2026-08-19 4:10 pm | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 72,725 | $19.94 | $1,450,419 | 393,564 (Direct) | View |
| 2026-08-17 Sale | 2026-08-19 4:10 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,000 | $20 | $20,000 | 175,526 (Direct) | View |
| 2026-08-11 Sale | 2026-08-12 4:10 pm | Avalo Therapeutics Inc. | AVTX | Riley Jennifer Chief Strategy Officer | 2,655 | $19.59 | $52,012 | 37,041 (Direct) | View |
| 2026-08-10 Sale | 2026-08-12 4:10 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $20 | $13,580 | 166,189 (Direct) | View |
| 2026-07-27 Sale | 2026-07-29 4:05 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,000 | $20 | $20,000 | 176,526 (Direct) | View |
| 2026-06-30 Sale | 2026-07-02 4:05 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 4,654 | $20 | $93,080 | 292,618 (Direct) | View |
| 2026-06-23 Sale | 2026-06-25 5:24 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,450 | $18 | $26,100 | 168,647 (Direct) | View |
| 2026-05-28 Sale | 2026-06-01 4:05 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $16 | $10,864 | 165,443 (Direct) | View |
| 2026-05-15 Sale | 2026-05-19 4:10 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,000 | $18.76 | $56,280 | 132,247 (Direct) | View |
| 2026-05-07 Sale | 2026-05-11 4:05 pm | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 18,606 | $24.12 | $448,818 | 168,517 (Direct) | View |
| 2026-05-06 Sale | 2026-05-07 4:18 pm | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 75,063 | $20.17 | $1,513,673 | 178,571 (Direct) | View |
| 2026-05-06 Sale | 2026-05-07 4:16 pm | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 47,000 | $20.19 | $948,722 | 116,423 (Direct) | View |
| 2026-05-05 Sale | 2026-05-07 4:16 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 108,234 | $20.61 | $2,230,367 | 611,427 (Direct) | View |
| 2026-05-06 Sale | 2026-05-07 4:15 pm | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 3,167 | $22.88 | $72,461 | 3,166 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-30 Option Award | 2026-10-02 4:15 pm | N/A 2036-09-30 | Avalo Therapeutics Inc. | AVTX | Jain Rita Director | 1,322 | $12.29 | 1,322 (Direct) | View |
| 2026-09-30 Option Award | 2026-10-02 4:15 pm | N/A 2036-09-30 | Avalo Therapeutics Inc. | AVTX | Lind Kevin Robert Director | 1,352 | $12.29 | 1,352 (Direct) | View |
| 2026-09-30 Option Award | 2026-10-02 4:15 pm | N/A 2036-09-30 | Avalo Therapeutics Inc. | AVTX | Philip Ron M Director | 1,109 | $12.29 | 1,109 (Direct) | View |
| 2026-09-16 Exercise | 2026-09-18 4:10 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 12,394 | $0 | 123,748 (Direct) | View |
| 2026-09-16 Exercise | 2026-09-18 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 12,394 | $9.88 | 123,748 (Direct) | View |
| 2026-09-10 Exercise | 2026-09-11 4:10 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 10,185 | $0 | 145,715 (Direct) | View |
| 2026-09-10 Exercise | 2026-09-11 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 10,185 | $8.04 | 145,715 (Direct) | View |
| 2026-08-28 Exercise | 2026-09-01 4:38 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $0 | 165,510 (Direct) | View |
| 2026-08-28 Exercise | 2026-09-01 4:38 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $8.04 | 165,510 (Direct) | View |
| 2026-08-17 Exercise | 2026-08-19 4:10 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 71,852 | $0 | 393,564 (Direct) | View |
| 2026-08-17 Exercise | 2026-08-19 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 71,852 | $9.88 | 393,564 (Direct) | View |
| 2026-08-17 Exercise | 2026-08-19 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,000 | $12.65 | 175,526 (Direct) | View |
| 2026-08-17 Exercise | 2026-08-19 4:10 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,000 | $0 | 175,526 (Direct) | View |
| 2026-08-10 Exercise | 2026-08-12 4:10 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $0 | 166,189 (Direct) | View |
| 2026-08-10 Exercise | 2026-08-12 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $8.04 | 166,189 (Direct) | View |
| 2026-07-27 Exercise | 2026-07-29 4:05 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,000 | $12.65 | 176,526 (Direct) | View |
| 2026-07-27 Exercise | 2026-07-29 4:05 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,000 | $0 | 176,526 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 4:05 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 2,875 | $12.65 | 292,618 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 4:05 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 4,654 | $0 | 292,618 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 4:05 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,779 | $8.04 | 292,618 (Direct) | View |
| 2026-06-30 Option Award | 2026-07-02 4:05 pm | N/A 2036-06-30 | Avalo Therapeutics Inc. | AVTX | Philip Ron M Director | 69 | $15.04 | 69 (Direct) | View |
| 2026-06-30 Option Award | 2026-07-02 4:05 pm | N/A 2036-06-30 | Avalo Therapeutics Inc. | AVTX | Lind Kevin Robert Director | 1,105 | $15.04 | 1,105 (Direct) | View |
| 2026-06-30 Option Award | 2026-07-02 4:05 pm | N/A 2036-06-30 | Avalo Therapeutics Inc. | AVTX | Jain Rita Director | 1,080 | $15.04 | 1,080 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 5:24 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,450 | $0 | 168,647 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 5:24 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,450 | $8.04 | 168,647 (Direct) | View |
| 2026-06-23 Option Award | 2026-06-25 5:24 pm | N/A 2036-06-23 | Avalo Therapeutics Inc. | AVTX | Philip Ron M Director | 40,200 | $0 | 40,200 (Direct) | View |
| 2026-06-10 Tax Withholding | 2026-06-12 4:43 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Riley Jennifer Chief Strategy Officer | 588 | $13.1 | 39,696 (Direct) | View |
| 2026-06-10 Tax Withholding | 2026-06-12 4:41 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 1,081 | $13.1 | 32,576 (Direct) | View |
| 2026-06-10 Tax Withholding | 2026-06-12 4:36 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 138 | $13.1 | 40,773 (Direct) | View |
| 2026-06-10 Tax Withholding | 2026-06-12 4:26 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,084 | $13.1 | 51,776 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-04 4:10 pm | N/A 2036-06-02 | Avalo Therapeutics Inc. | AVTX | Lind Kevin Robert Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-04 4:10 pm | N/A 2036-06-02 | Avalo Therapeutics Inc. | AVTX | Truex Samantha Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-04 4:10 pm | N/A 2036-06-02 | Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-04 4:10 pm | N/A 2036-06-02 | Avalo Therapeutics Inc. | AVTX | KANTOFF AARON Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-04 4:10 pm | N/A 2036-06-02 | Avalo Therapeutics Inc. | AVTX | Heffernan Michael Thomas Director | 29,500 | $0 | 29,500 (Direct) | View |
| 2026-06-02 Option Award | 2026-06-04 4:10 pm | N/A 2036-06-02 | Avalo Therapeutics Inc. | AVTX | Jain Rita Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2026-05-28 Exercise | 2026-06-01 4:05 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $0 | 165,443 (Direct) | View |
| 2026-05-28 Exercise | 2026-06-01 4:05 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 679 | $8.04 | 165,443 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Riley Jennifer Chief Strategy Officer | 34,200 | $0 | 36,855 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 39,900 | $0 | 40,323 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 24,300 | $0 | 27,934 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 43,500 | $0 | 47,122 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Executive Officer | 100,200 | $0 | 190,314 (Direct) | View |
| 2026-05-15 Exercise | 2026-05-19 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,000 | $12.65 | 132,247 (Direct) | View |
| 2026-05-15 Exercise | 2026-05-19 4:10 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 3,000 | $0 | 132,247 (Direct) | View |
| 2026-05-07 Exercise | 2026-05-11 4:05 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 18,606 | $0 | 168,517 (Direct) | View |
| 2026-05-07 Exercise | 2026-05-11 4:05 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 18,606 | $9.88 | 168,517 (Direct) | View |
| 2026-05-06 Exercise | 2026-05-07 4:18 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 62,500 | $13.43 | 178,571 (Direct) | View |
| 2026-05-06 Exercise | 2026-05-07 4:18 pm | N/A 2034-06-24 | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 75,063 | $0 | 178,571 (Direct) | View |
| 2026-05-06 Exercise | 2026-05-07 4:18 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 12,563 | $8.04 | 178,571 (Direct) | View |
| 2026-05-06 Exercise | 2026-05-07 4:16 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 47,000 | $0 | 116,423 (Direct) | View |
| 2026-05-06 Exercise | 2026-05-07 4:16 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 47,000 | $8.04 | 116,423 (Direct) | View |
| 2026-05-05 Exercise | 2026-05-07 4:16 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 78,905 | $12.65 | 611,427 (Direct) | View |
| 2026-05-05 Exercise | 2026-05-07 4:16 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 108,234 | $0 | 611,427 (Direct) | View |
| 2026-05-05 Exercise | 2026-05-07 4:16 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 29,329 | $8.04 | 611,427 (Direct) | View |